SomnoMed Limited

ASX:SOM 주식 보고서

시가총액: AU$54.6m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

SomnoMed 미래 성장

Future 기준 확인 0/6

SomnoMed의 수익이 증가할 것으로 예상됨입니다.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Medical Equipment 수익 성장16.6%
매출 성장률4.9%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트06 May 2024

최근 미래 성장 업데이트

Recent updates

SomnoMed Limited (ASX:SOM) Shares Fly 30% But Investors Aren't Buying For Growth

May 31
SomnoMed Limited (ASX:SOM) Shares Fly 30% But Investors Aren't Buying For Growth

SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Apr 15
SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Mar 04
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)

Dec 21
Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)

SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks

Sep 02
SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks

Is SomnoMed (ASX:SOM) Using Too Much Debt?

Jun 19
Is SomnoMed (ASX:SOM) Using Too Much Debt?

It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year

Nov 18
It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year

SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Sep 27
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Is SomnoMed (ASX:SOM) Using Debt Sensibly?

May 10
Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Oct 26
Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?

May 12
Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?

Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?

Mar 02
Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?

Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?

Feb 01
Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?

Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?

Dec 28
Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?

Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?

Dec 01
Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?

Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)

Jul 28
Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)

SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings

Jul 14
SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings

수익 및 매출 성장 예측

ASX:SOM - 애널리스트의 미래 추정치 및 과거 재무 데이터 (AUD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
6/30/2026100N/AN/AN/A1
6/30/202592N/AN/AN/A1
6/30/202489N/AN/AN/A1
12/31/202389-11-10-5N/A
9/30/202386-9-10-4N/A
6/30/202384-8-10-4N/A
3/31/202381-7-11-3N/A
12/31/202279-5-11-2N/A
9/30/202276-5-90N/A
6/30/202273-4-72N/A
3/31/202269-5-61N/A
12/31/202166-5-6-1N/A
9/30/202164-3-41N/A
6/30/202163-1-13N/A
3/31/202159-125N/A
12/31/202055-157N/A
9/30/202056-146N/A
6/30/202057035N/A
3/31/202060002N/A
12/31/2019631-4-1N/A
9/30/2019610-6-4N/A
6/30/2019590-8-7N/A
3/31/2019582N/AN/AN/A
12/31/2018563-9-7N/A
9/30/2018543-10-8N/A
6/30/2018522-12-9N/A
3/31/201851-1N/AN/AN/A
12/31/201750-4-11-8N/A
9/30/201750-4N/A-5N/A
6/30/201749-3N/A-3N/A
3/31/201748-2N/A-1N/A
12/31/201647-1N/A0N/A
9/30/2016450N/A1N/A
6/30/2016440N/A2N/A
3/31/2016420N/A2N/A
12/31/2015391N/A1N/A
9/30/2015371N/A0N/A
6/30/2015341N/A0N/A
3/31/2015341N/A0N/A
12/31/2014351N/A-1N/A
9/30/2014321N/A-1N/A
6/30/2014300N/A-1N/A
3/31/2014260N/A0N/A
12/31/2013220N/A0N/A
9/30/2013200N/A0N/A

애널리스트 미래 성장 예측

수입 대 저축률: SOM 의 예상 수익 증가율이 절약률( 2.3% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: SOM 의 수익이 Australian 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: SOM 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: SOM 의 수익(연간 4.9% ) Australian 시장( 5.5% 보다 느리게 성장할 것으로 예상됩니다. 5.5% 연간).

고성장 수익: SOM 의 수익(연간 4.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: SOM 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견